I appreciate that this paper was applauded for its thoughtful approach to assessing “prescription drug labels (PDLs)” using rhetorical principles. However, I believe the authors’ invention of the composite artifact “PDL” and their subsequent assessment based on this flawed concept is problematic and may weaken the validity of their conclusions.